iCAD, Inc. Reports Second Quarter Financial Results

iCAD, Inc. (Nasdaq:ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, today reported financial results for the three and six months ended June 30, 2014.

“We are pleased to report another strong quarter of financial performance and our eighth consecutive quarter of top-line growth and positive non-GAAP adjusted EBITDA. These results include revenue growth of 25% in the quarter as compared to the same quarter last year, with strong contributions from both our Therapy and Cancer Detection products. Importantly, recurring services revenue grew by 27% for the second quarter and by 33% for the first six months, and represents an important foundation for future growth,” stated Ken Ferry, President and Chief Executive Officer.

Help employers find you! Check out all the jobs and post your resume.